Pharmacokinetics of Levodopa before and after Gastrointestinal Resection in Parkinson's Disease
Open Access
- 18 September 2015
- journal article
- Published by S. Karger AG in Case Reports in Neurology
- Vol. 7 (3) , 181-185
Abstract
Introduction: Levodopa (LD) is important in the clinical treatment of Parkinson's disease (PD), and the changes of its pharmacokinetics may affect the clinical outcome. LD is mainly absorbed in the upper intestine; thus, the pharmacokinetics of LD may change after gastrointestinal operation. Here, we present the case of a patient who underwent resection of the intestine and compared his LD pharmacokinetics before and after resection. Case Presentation: A 72-year-old Japanese male PD patient developed jaundice and was diagnosed with cholangiocarcinoma. Pancreaticoduodenectomy was performed and part of the stomach, total duodenum, and part of the jejunum were resected. The patient had been treated with LD, and his pharmacokinetics was checked twice at the age of 68 years. Because LD is absorbed in the duodenum and jejunum, we checked his pharmacokinetics again after the operation. The results before the operation were almost similar; however, in comparison, the area under the curve and peak drug concentration was reduced, and the time-to-peak drug concentration and elimination halftime were elongated after the operation. Conclusion: Physicians must pay attention to the change of LD pharmacokinetics after gastrointestinal operation.Keywords
This publication has 13 references indexed in Scilit:
- Sex Differences in the Pharmacokinetics of Levodopa in Elderly Patients With Parkinson DiseaseClinical Neuropharmacology, 2014
- Influence of ageing on the pharmacokinetics of levodopa in elderly patients with Parkinson’s diseaseParkinsonism & Related Disorders, 2011
- Pharmacokinetic Optimisation in the Treatment of Parkinson???s DiseaseClinical Pharmacokinetics, 2006
- Gastrointestinal dysfunction in Parkinson's diseaseThe Lancet Neurology, 2003
- Levodopa Pharmacokinetics and Motor Performance During Activities of Daily Living in Patients With Parkinson's Disease on Individual Drug CombinationsClinical Neuropharmacology, 2002
- Body Weight Influences Pharmacokinetics of Levodopa in Parkinson's DiseaseClinical Neuropharmacology, 2002
- Clinical Pharmacokinetic and Pharmacodynamic Properties of Drugs Used in the Treatment of Parkinson??s DiseaseClinical Pharmacokinetics, 2002
- Chronic levodopa therapy enhances dopa absorption: Contribution to wearing-offJournal of Neural Transmission, 1996
- The effect of L‐leucine on the absorption of levodopa, studied by regional jejunal perfusion in man.British Journal of Clinical Pharmacology, 1993
- Intestinal absorption of levodopa in manEuropean Journal of Clinical Pharmacology, 1983